Urolithin A Mitigates Renal Fibrosis by Promoting Fatty Acid Oxidation Through Orchestrating β‐Catenin Signaling
The FASEB Journal · 15.07.2026 · 40 (13)
DOI: 10.1096/fj.202601350rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 03.07.2026. Verfasst von Yao Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hunan International Joint Laboratory of Animal Intestinal Ecology and Health, Laboratory of Animal Nutrition and Human Health, College of Life Scienc…. Hauptthemen laut MEDLINE: beta Catenin, Coumarins, Fibrosis, Fatty Acids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China (NSFC), Natural Science Foundation of Hunan Province, Scientific Research Foundation of Hunan Provincial Education Department.
Abstract (Originalsprache)
Kidney fibrosis, a progressive outcome of various chronic kidney diseases (CKD), features tubule atrophy, chronic interstitial inflammation, and abnormal metabolic changes. Urolithin A (UA), a gut microbiome metabolite derived from ellagic acid and ellagitannins, has anti‐inflammatory and anti‐obesity effects and enhances cellular health by promoting mitophagy and mitochondrial function. This study aimed to evaluate the protective effects of UA against renal fibrosis in mice with unilateral ureteral obstruction (UUO) and to investigate its underlying mechanisms. UA significantly reduced lipid deposition and mitigated renal fibrosis in the kidneys of UUO mice and TGFβ1‐induced HK‐2 cells. Mechanistically, UA alleviated renal fibrosis by inhibiting GSK3β/β‐catenin signaling to promote FAO, rather than through the canonical TGF‐β1/Smad or Notch1 signaling pathways. Furthermore, UA activates GSK3β to inhibit β‐catenin via AKT1 but independent of SIRT3 or PP2A. Altogether, UA significantly mitigated kidney fibrosis by restoring fatty acid oxidation metabolism through inactivation of the GSK3β/β‐catenin axis, offering potential as an alternative therapy to combat renal fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hunan International Joint Laboratory of Animal Intestinal Ecology and Health, Laboratory of Animal Nutrition and Human Health, College of Life Sciences, Hunan Normal University, Changsha, People's Republic of China.
ORCID-Profile: Wuzheng Zhu
Förderung
- National Natural Science Foundation of China (NSFC)
- Natural Science Foundation of Hunan Province
- Scientific Research Foundation of Hunan Provincial Education Department
Zitieren
APA
Li, Y., Wei, J., Li, J., & Zhu, W. (2026). Urolithin A Mitigates Renal Fibrosis by Promoting Fatty Acid Oxidation Through Orchestrating β‐Catenin Signaling. The FASEB Journal, 40(13). https://doi.org/10.1096/fj.202601350rr
Vancouver
Li Y, Wei J, Li J, Zhu W. Urolithin A Mitigates Renal Fibrosis by Promoting Fatty Acid Oxidation Through Orchestrating β‐Catenin Signaling. The FASEB Journal. 2026;40(13). doi:10.1096/fj.202601350rr
BibTeX
@article{Li2026,
author = {Li, Yao and Wei, Jingjing and Li, Jiaqi and Zhu, Wuzheng},
title = {Urolithin A Mitigates Renal Fibrosis by Promoting Fatty Acid Oxidation Through Orchestrating β‐Catenin Signaling},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {13},
doi = {10.1096/fj.202601350rr}
}
EUVIMED